inflammatory myofibroblastic tumor
GPTKB entity
Statements (49)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:can_metastasize_to |
gptkb:theorem
|
gptkbp:complications |
gptkb:theorem
|
gptkbp:displacement |
malignant tumors
other tumors benign lesions |
https://www.w3.org/2000/01/rdf-schema#label |
inflammatory myofibroblastic tumor
|
gptkbp:is_a |
soft tissue tumor
|
gptkbp:is_associated_with |
gptkb:IL-6
genetic mutations chromosomal abnormalities anaplastic lymphoma kinase (ALK) gene |
gptkbp:is_characterized_by |
plasma cells
lymphocytes inflammatory infiltrate proliferation of myofibroblasts spindle-shaped cells |
gptkbp:is_considered_as |
a rare tumor
|
gptkbp:is_described_as |
gptkb:academic_journal
|
gptkbp:is_often_used_in |
gptkb:Person
young adults |
gptkbp:is_part_of |
oncology
pediatric tumors soft tissue neoplasms |
gptkbp:is_recognized_by |
immunohistochemistry
histopathological examination molecular testing |
gptkbp:is_related_to |
inflammatory response
|
gptkbp:is_studied_in |
gptkb:hospital
|
gptkbp:is_used_for |
fever
pain swelling |
gptkbp:occurs_in |
lungs
gastrointestinal tract abdominal cavity head and neck retroperitoneum |
gptkbp:rarity |
older adults
|
gptkbp:scientific_classification |
gptkb:healthcare_organization
|
gptkbp:social_responsibility |
gptkb:healthcare_organization
imaging studies biopsy variable prognosis fibromatosis |
gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy |
gptkbp:bfsParent |
gptkb:letrozole
|
gptkbp:bfsLayer |
5
|